Last quarter (Q4 2023), ReShape Lifesciences's total revenue was $1.98M, a decrease of -36.27% from the same quarter last year. In Q4, ReShape Lifesciences's net income was $-1.70M. See ReShape Lifesciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 8.68M	$ 8.68M	$ 11.24M	$ 13.60M	$ 11.30M	$ 15.09M
Cost of Revenue	$ 3.13M	$ 3.13M	$ 4.44M	$ 5.25M	$ 5.04M	$ 5.78M
Gross Profit	$ 5.55M	$ 5.55M	$ 6.80M	$ 8.35M	$ 6.26M	$ 9.30M
Operating Expense	$ 20.93M	$ 20.93M	$ 33.88M	$ 66.23M	$ 18.72M	$ 25.19M
Operating Income	$ -15.38M	$ -15.38M	$ -27.08M	$ -27.23M	$ -12.46M	$ -15.89M
Net Non Operating Interest Income Expense	$ 26.00K	$ 26.00K	$ -113.00K	$ -832.00K	$ -2.05M	$ -451.00K
Other Income Expense	$ -3.26M	$ -3.26M	$ 518.00K	$ 2.06M	$ -7.30M	$ -58.76M
Pretax Income	$ -11.34M	$ -11.34M	$ -46.59M	$ -63.42M	$ -21.81M	$ -75.10M
Tax Provision	$ 52.00K	$ 52.00K	$ -380.00K	$ -274.00K	$ -181.00K	$ -893.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -11.39M	$ -11.39M	$ -46.21M	$ -63.15M	$ -21.63M	$ -74.21M
Basic EPS	$ -1.91	$ -1.91	$ -108.90	$ -288.97	$ -3.12	$ -42.93
Diluted EPS	$ -1.91	$ -1.91	$ -108.90	$ -288.97	$ -3.12	$ -42.93
Basic Average Shares	$ 23.83M	$ 5.96M	$ 424.39K	$ 218.52K	$ 6.93M	$ 1.73M
Diluted Average Shares	$ 23.83M	$ 5.96M	$ 424.39K	$ 218.52K	$ 6.93M	$ 1.73M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 24.06M	$ 24.06M	$ 38.32M	$ 71.48M	$ 23.76M	$ 30.98M
Net Income From Continuing And Discontinued Operation	$ -11.39M	$ -11.39M	$ -46.21M	$ -63.15M	$ -21.63M	$ -74.21M
Normalized Income	$ -8.21M	$ -8.21M	$ -8.96M	$ -2.40M	$ -14.39M	$ -17.47M
Interest Expense	-	-	-	-	$ 2.05M	$ 451.00K
EBIT	$ -11.34M	$ -11.34M	$ -46.59M	$ -63.42M	$ -19.76M	$ -74.65M
EBITDA	$ -11.18M	$ -11.18M	$ -44.46M	$ -60.99M	$ -18.09M	$ -72.94M

Currency in USD

ReShape Lifesciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing